General Information of Drug (ID: DM2AZPP)

Drug Name
Hepzato
Indication
Disease Entry ICD 11 Status REF
Uveal Melanoma 2D0Y Phase 3 [1]
Cross-matching ID
PubChem CID
9927978
TTD ID
DFB62M
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug
Combinatorial Drugs (CBD) Click to Jump to the Detailed CBD Information of This Drug

References

1 ClinicalTrials.gov (NCT05022901) An Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in Patients With Hepatic Dominant Ocular Melanoma. U.S.National Institutes of Health.